Furthermore, either c-MET or p-MET is more often highly expressed in cases with tumor located in the upper part of stomach, larger than 35% of metastatic lymph node ratio, severer lymph node involvement, <20 months of survival, later stage of TNM and stronger proliferation of cells (higher expression of Ki-67). This evidence concerns the gene MKI67 and neoplasm.